We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a ...

A special congressional committee has recommended a $15 billion investment to boost the United States' biotech advantage over ...

The much-publicized introduction of genetically modified cubs that share features of extinct dire wolves sparked claims ...

United Biotechnology will retain the rights for UBT251 in Chinese mainland, Hong Kong, Macau, and Taiwan. United Biotechnology is eligible to receive an upfront payment of 200 million US dollars and ...

We recently published a list of 7 Most Profitable Biotech Stocks To Buy Right Now. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands ...

United Biotechnology will get $200M upfront, up to $1.8B in milestones, and royalties as part of its UBT251 licensing deal with Novo Nordisk A phase 1b trial of UBT251 showed a 15.1% weight loss ...

“We look forward to building on United Biotechnology’s scientific work and further exploring the potential best-in-class properties of UBT251 across cardiometabolic disease indications.

United Biotechnology will retain the rights for UBT251 in Chinese mainland, Hong Kong, Macau, and Taiwan. United Biotechnology is eligible to receive an upfront payment of 200 million US dollars and ...